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The Severe Acute Respiratory Syndrome CoronaVirus type 2 (SARS-CoV-2) pandemic
impacted the organization of paediatric hospitals. This study aimed to evaluate the
preparedness for the pandemic among a European network of children’s hospitals and
to explore the strategies to restart health care services. A cross-sectional, web-based
survey was distributed in May 2020 to the 13 children’s tertiary care hospitals belonging
to the European Children’s Hospitals Organisation. Responses were obtained from eight
hospitals (62%). Significant reductions were observed in accesses to the emergency
departments (41.7%), outpatient visits (35.7%), intensive and non-intensive care unit
inpatient admissions (16.4 and 13%, respectively) between February 1 and April 30,
2020 as compared with the same period of 2019. Overall, 93 children with SARS CoV-2
infection were admitted to inpatient wards. All the hospitals created SARS-CoV-2
preparedness plans for the diagnosis and management of infected patients. Routine
activities were re-scheduled. Four hospitals shared their own staff with adult units, two
designated bed spaces for adults and only one admitted adults to inpatient wards.
The three main components for the resumption of clinical activities were testing, source
control, and reorganization of spaces and flows. Telemedicine and telehealth services
were used before the SARS-CoV-2 pandemic by three hospitals and by all the hospitals
during it.
Conclusion: The present study provides a perspective on preparedness to
SARS-CoV-2 pandemic among eight large European children’s hospitals, on the impact
of the pandemic on the hospital activities and on the strategies adopted to restart
clinical activities.
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INTRODUCTION
In December 2019 a novel beta-coronavirus, now
officially known as Severe Acute Respiratory Syndrome
CoronaVirus type 2 (SARS-CoV-2), emerged in Wuhan,
Hubei Province, China, causing a series of severe cases
of pneumonia. The virus spread rapidly worldwide and
in March 2020 the World Health Organisation (WHO)
declared SARS-CoV-2 infection to be a pandemic. As of
February 2021, the WHO dashboard (1) reports that there
have been more than 111 million confirmed cases and
almost 2.5 million deaths; of these, 37 million confirmed
cases, including 884 thousand deaths, were reported in
European countries (1).
Paediatric cases of SARS-CoV-2 infection accounted for 2%
of the total cases diagnosed in China, 1.2% in Italy, and 5% in
the United States (2). In children, SARS-CoV-2 infection and
the correlated syndrome denominated COronaVIrus DIsease-
2019 (COVID-19) is clinically much different from that in adults.
According to the clinical categories described by Dong (3),
the majority of infected children were asymptomatic or had
mild disease and rarely developed severe or critical conditions
(4). Children generally had a faster recovery and a better
prognosis than adults (5), and deaths were extremely rare.
Relatively few pediatric COVID-19 cases were hospitalized and
even fewer warranted admission to the paediatric intensive
care unit (6–8). Increased hospitalizations were observed in
children with underlying long-term medical conditions (LTC),
that have higher risk of more severe illness (6–8). Due to
the subtle clinical presentation, children were probably less
tested and not accurately counted among observed SARS-CoV-
2 infection cases. Therefore, although COVID-19 has been
described in children at a lower case rate relative to adults, it
is likely that the infection rate may be similar (9). Specific to
paediatric age, a new inflammatory illness, subsequently named
multi-inflammatory syndrome in children and neurological
manifestations (including stroke) have been described in children
with COVID-19 (10, 11).
The SARS-CoV-2 pandemic has been defined as a mass
casualty incident because of its catastrophic effect on public
health. The effectiveness of the response to an emergency
depends on the availability of adequate human, structural,
and economic resources but also on the ability to manage
logistics (10). Kandel et al. analysed global operational readiness
to prevent, detect and respond to an outbreak of a novel
infectious disease, including COVID-19 (10). The 182 countries
involved vary widely in terms of preparedness; the authors found
that only 57% have strong national and subnational capacities
in place (10).
The aims of the present study were to investigate the
preparedness for the COVID-19 pandemic among a European
network of children’s hospitals, determine common strengths,
and critically assess any shortcomings. The possible strategies to
restart paediatric health care services were analysed, collecting
the lessons learned in order to improve and address future
preparedness plans.
MATERIALS AND METHODS
The European Children’s Hospitals
Organisation Network and Survey
Participants
The European Children’s Hospitals Organisation (ECHO) is a
new organisation, established in 2017, representing many of
the leading children’s hospitals across Europe (https://www.
echohospitals.org/). These hospitals take care of some of the
most complex patients in Europe and around the world. ECHO’s
mission is to advocate for children’s health and their access to
the best quality care through the collaborative work of children’s
hospitals. This includes joint initiatives to improve the quality of
care provided at member hospitals. For this study, a structured
survey was conducted within the ECHO network. Thirteen
hospitals in 13 different countries (Denmark, France, Germany,
Ireland, Island, Israel, Italy, Latvia, Netherland, Norway, Poland,
Spain, and United Kingdoms) involved in the management of the
COVID-19 pandemic received an emailed invitation to complete
the web-based survey [implemented using REDCap (12)] in
May 2020. Respondents did not receive any honorarium for
completing the survey. One person for each centre completed
the survey, the chief executive officer of the hospitals or a
delegate of his choice. Ethical approval was not required for
this service evaluation study because individual patient data was
not collected.
Survey Content and Development
The survey was written in English and consisted of 85 items
divided into 6 sections: (1) general information; (2) preparedness;
(3) healthcare professionals; (4) healthcare settings; (5)
access to the hospital; (6) preparedness for reopening (see
Supplementary Material). The items and the sections were
based on the guidelines and recommendations provided by the
WHO (13), Centers for Disease Control and Prevention (14)
and European Centre for Disease Prevention and Control (15).
The survey was piloted with two Italian clinicians/respondents
to assess clarity and validity. Only one of the two was among the
respondents to the survey. Modifications were made based on
feedback and comments. The impact of COVID-19 on hospital
outcomes was evaluated by comparing the activity performed
between February 1 and April 30 of 2019 (before COVID-19)
and 2020 (during COVID-19). The activity was assessed by
taking into account outpatient visits, emergency department
attendance, non-intensive care unit and intensive care unit
inpatient numbers in the two periods.
Statistical Analysis
Standard descriptive statistics were used to describe response
frequency. Missing data were not replaced for this descriptive
analysis. Denominators were specified across the result
section in order to make clear the response rate. All
analyses were conducted using MedCalc Statistical Software
version 17.6 (MedCalc Software bvba, Ostend, Belgium;
http://www.medcalc.org; 2017).
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RESULTS
Responses were obtained from eight (62%) of the 13 hospitals
invited to complete the survey from the following countries:
Ireland, Dublin, Children’s Health Ireland (Dublin CHI);
Finland, Helsinki, HUSNewChildren’s Hospital (Helsinki HUS);
Italy, Florence, Meyer Children’s Hospital (Florence MCH);
The Netherlands, Rotterdam, Erasmus MC-Sophia Children’s
Hospital (Rotterdam EMC-SCH); Latvia, Riga, Children’s
Clinical University Hospital (Riga CCUH); Poland, Warsaw, The
Children’s Memorial Health Institute (Warsaw CMHI); Spain,
Barcelona, Sant Joan de Déu Barcelona Children’s Hospital
(Barcelona SJD); and United Kingdom, London, Great Ormond
Street Hospital (London GOSH).
Characteristics of the Participating
Hospitals
The characteristics of the participating hospitals are reported
in Supplementary Table A. The median number of inpatient
beds per hospital was 314.5 (range 163–596). Seven out of eight
hospitals had an emergency department with >8,000 annual
attendances (median 43,111, range 8,000–122,382).
Comparison of the Activities of the
Hospitals in 2019 and 2020
Significant reductions were observed when the number of
outpatient visits, emergency department attendances, ICU and
non-ICU inpatient admissions between February 1 and April 30,
2020 were compared with the same period of 2019 (Table 1).
The most relevant reduction rate was observed in accesses to
the emergency departments (41.7%) followed by outpatient visits
(35.7%), intensive care unit and non-intensive care unit inpatient
admissions (16.4 and 13%, respectively).
SARS-CoV-2 Infection Cases
During the study period, 41 confirmed SARS-CoV-2 infection
cases were evaluated at the ED, 93 were admitted to paediatric
wards, 21 to intensive care units and 13 were transferred to
the intensive care unit from another ward within the hospital
due to worsening clinical condition. A total of 29 children with
SARS-CoV-2 infection were admitted to the hospital for different
reasons and found to be infected during hospitalization. Data
according to each hospital are summarized in Table 2.
Preparedness Plan-Hospital Strategies
All the eight involved hospitals created a multidisciplinary
planning committee that developed written SARS-CoV-2
infection preparedness plans for the evaluation, diagnosis,
and management of confirmed or suspected COVID-19
patients. SARS-CoV-2 infection communication plans were
also developed by all hospitals in order to share information
and relevant policies with department/unit heads, facility staff,
families, volunteers, and other people accessing the facility.
Routine activities, such as elective procedures, non-urgent
outpatient visits, ancillary exams, or training or scientific
sessions for health professionals were re-scheduled or cancelled.
Two hospitals (25%) designated bed spaces for adults with
COVID-19 and one (12.5%) admitted adults with COVID-19
in both intensive care unit or non- intensive care unit beds. A
separate emergency department area for the triage, assessment
and management of children with fever or respiratory symptoms
was created by five out of six hospitals (83.3%). All the hospitals
identified a designated area to admit and isolate patients with
suspected COVID-19 and a specific ward to admit and isolate
patients with known SARS-CoV-2 infection. The hospital that
admitted adults with COVID-19, also increased the number of
airborne infection isolation rooms by 10 units. Less than 50% of
these rooms were used at the same time. Two hospitals increased
the number of intensive care unit beds with mechanical
ventilators (one by 25%, the other by 48%), which were not
actively used in the reporting period. All hospitals limited the
number of parents or caregivers to one person per patient; three
(37.5%) created a specific register of all visitors who entered
and exited the room of a subject with confirmed/suspected
SARS-CoV-2 infection. All parents or caregivers were screened
for fever or respiratory symptoms in three (37.5%) and five
(62.5%) hospitals, respectively. Nasopharyngeal swabs were
performed on all parents in one hospital (1/7; 14.3%) and only in
selected cases in the remaining six (6/7; 85.7%).
Care of Patients With LTC or Special
Healthcare Needs (SHCN)
In order to continue the routine care for non-COVID-19
patients with LTC or SHCN, different strategies were adopted.
All the hospitals (n 7) identified and maintained the essential
services that the hospital provides at all times and under any
circumstances. Five hospitals (5/7; 71.4%) developed resources
for children living with LTC or SHCN, such as print- and web-
based educational materials and access to support telephone
lines. Six hospitals (6/7; 85.7%) proactively reviewed LTC or
SHCN patients requiring care and their possible needs if
healthcare services were disrupted or identified clear points of
contact for LTC and SHCN. Three hospitals (3/7; 42.9%) reached
out to family paediatricians or organizations/foundations to
provide local specific advice or services. Four hospitals (4/7;
57.1%) provided mental health resources to help parents
manage stress, employ coping strategies and promote adaptive
behaviour changes.
Health Care Professionals
Strategies for testing SARS-CoV-2 infection in health care
professionals are summarized in Table 3. Adopted strategies
for screening were nasopharyngeal swab (6/7; 85.7%), serologic
tests (2/7, 28.6%), or both (1/7, 14.3%). Healthcare professionals
were also supported by mental health resources to help manage
stress, employ coping strategies and promote adaptive behaviour
change (5/7; 71.4%) and were trained (and retrained) on personal
protective equipment to acquire competency with selection and
proper use (7/7; 100%). In four hospitals (57.1%), the paediatric
staff helped the staff of adult units to cover shortages, including
providing adult care within their own hospitals or providing care
at an outside adult hospital.
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Outpatient visits 2019 64156 74182 13555 60708 56662 58625 59666.5 13555–74182
2020 37401 50885 13546 39398 53896 29237 38399.5 13546–53896
Difference (%) −41.7 −31.4 −0.1 −35.1 −4.9 −50.1 −35.6 -
Emergency department attendances 2019 32123 12366 11687 n.a. 1895 n.a. 6791.0 0–32123
2020 23257 6129 8758 n.a. 1784 n.a. 3956.5 0–23257
Difference (%) −27.6 −50.4 −25.1 - −5.9 - −41.7 -
Non-intensive care unit inpatients 2019 5192 2315 2358 10314 4174 9844 4683.0 2315–10314
2020 4733 1493 1907 7847 3414 6327 4073.5 1493–7847
Difference (%) −8.8 −35.5 −19.1 −23.9 −18.2 −35.7 −13.0 -
Intensive care unit inpatients 2019 324 24 512 394 394 345 369.5 24–512
2020 293 27 400 364 325 270 309.0 27–400
Difference (%) −9.6 12.5 −21.9 −7.6 −17.5 −21.7 −16.4 -
Cumulative cases per country* no/100, 000 456.6 335.4 88.8 250.7 219.9 33.3
Barcelona SJD, Barcelona, Sant Joan de Déu Barcelona Children’s Hospital; Dublin CHI, Dublin, Children’s Health Ireland; Florence MCH, Florence, Meyer Children’s Hospital; Helsinki
HUS, Helsinki, HUS New Children’s Hospital; London GOSH, London, Great Ormond Street Hospital; Rotterdam EMC-SCH, Rotterdam, Erasmus MC-Sophia Children’s Hospital;
Warsaw CMHI, Warsaw, The Children’s Memorial Health Institute; n.a., not applicable because these hospitals do not have emergency departments; *Data are from March 1 to April
30, 2020 – source World Health Organization.















Evaluated at emergency departments 28 3 3 0 7 0 0
Admitted to wards 41 13 0 33 6 0 0
Admitted to intensive care units 3 0 0 18 0 0 0
Transferred to intensive care units* 1 0 0 11 0 1 0
Admitted for other reasons 10 1 0 17 0 1 0
Barcelona SJD, Barcelona, Sant Joan de Déu Barcelona Children’s Hospital; Florence MCH, Florence, Meyer Children’s Hospital; Helsinki HUS, Helsinki, HUS New Children’s
Hospital; London GOSH, London, Great Ormond Street Hospital; Riga CCUH, Riga, Children’s Clinical University Hospital; Rotterdam EMC-SCH, Rotterdam, Erasmus MC-Sophia
Children’s Hospital; Warsaw CMHI, Warsaw, The Children’s Memorial Health Institute; m.d., missing data; n.a., not applicable; *Patients transferred from another ward for worsening
clinical condition.
TABLE 3 | Strategies for testing SARS-CoV-2 infection on health care
professionals.
Health care professionals n (%)*
Testing only workers who developed signs or symptoms
compatible with COVID-19
3 (42.9%)
Testing selected workers belonging to specific exposure
risk categories
1 (14.3%)
Testing all workers at the hospital (including non-clinical
staff)
1 (14.3%)
*Data available from seven paediatric hospitals.
Strategies for Resumption of
Clinical Activities
The three main components of the strategic planning process
for the resumption of clinical activities were testing, source
control, and reorganization of spaces and flows of patients
and are summarized in Supplementary Table B. Four out of
seven hospitals (57.1%) will permanently maintain a designated
ward/unit for patients with confirmed SARS-CoV-2 infection.
Centralization of children with known COVID-19 to a single
local/regional referral hospital was considered reasonable and
effective by three hospitals (3/7; 42.8%); four (57.1%) created a
trained in-hospital contact tracing program and workforce. All
the hospitals have developed a stepwise approach to restart all
healthcare services as described in Table 2.
Telemedicine and Telehealth
Telemedicine and telehealth services were used before the SARS-
CoV-2 pandemic by three (3/8; 37.5%) hospitals and by all the
hospitals during it.
DISCUSSION
The present study, based on a survey completed by eight
European children’s hospitals, explored the preparedness for
COVID-19, the impact of the pandemic on hospital activities,
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and the strategies adopted to restart the paediatric health
care services. The main pillars of preparedness response were
homogeneous across the different hospitals. Overall, a significant
reduction in the number of inpatients, outpatients, and
attendances to the emergency departments was observed.
Different approaches were used for reopening and the
resumption of activities.
Preparedness for health emergencies includes all plans
developed in anticipation of a crisis and is essential to provide an
effective response to pandemics. In all of the children’s hospitals
involved in the survey, a preparedness plan was developed and
implemented to ensure a rapid and effective response to COVID-
19, to provide care to a possible high volume of SARS-CoV-2
infected children and to prevent nosocomial outbreaks. Most
of the measures applied were inspired by the adult models and
in line with the guidelines released by the major international
organizations (13–15). The response was similar across the
different hospitals. In all the hospitals, a written SARS-CoV-2
infection preparedness plan for the evaluation, diagnosis, and
management of confirmed or suspected COVID-19 was put in
place and communicated to staff, patients, and families with
the main aims of protecting patients, healthcare personnel and
visitors from COVID-19. Routine non-urgent activities were
postponed and only essential services were maintained. Access
to the facility was restricted to one parent/caregiver per patient,
assessed for fever or respiratory symptoms. All the hospitals
reorganized spaces and flows of patients. Children with suspected
or known SARS-CoV-2 infection were admitted to dedicated
areas of the emergency department and moved to dedicated
inpatient wards. Healthcare professionals were trained and
retrained in the correct use of personal protective equipment and
were tested and retested for SARS-CoV-2 with nasopharyngeal
swabs, serological tests or both.
It was of interest to evaluate whether the response plan
was oriented toward optimizing services and adopting
alternative models of care as per WHO recommendations (13).
Telemedicine, the practice that allows healthcare professionals
to evaluate, diagnose, and treat patients at a distance using
telecommunications technology, was implemented as a possible
solution to overcome the barriers of social distancing. Only three
hospitals were providing telemedicine prior to the pandemic
reflecting the low investments in digital health in the past. Health
information and digital health solutions are playing a key role
in coping with the ongoing COVID-19 outbreak contributing
positively to the resilience of the health service delivery system.
Future investments should certainly take communicable
diseases into consideration and telemedicine as an essential
tool to ensure the provision and continuity of care reducing
face-to-face contact (16, 17).
In the pandemic scenario, children with disabilities or chronic
conditions, including respiratory diseases, immunodeficiencies
and cancers, are highly vulnerable (18). These children require
continuous monitoring, assistance and access to treatments but,
at the same time, need to be protected from possible exposure to
the virus as they are at increased risk of severe illness (16, 18).
The preparedness response for children with LTC or SHCN
among the eight children’s hospitals was variable. Improvements
could come from informing individuals as to what their level of
risk may be so they can make individual decisions about illness
prevention and from increasing the awareness of hospitals and
clinicians in order to develop specific resources.
COVID-19 has been recognized as a traumatic experience
directly influencing the mental health of children. Social isolation
and loneliness were associated with anxiety and depression in
children and adolescents. Mental health support to help patients
and families to manage COVID-19 stressors was provided
by only four hospitals involved in the survey. Indeed, even
in view of a possible second wave of the pandemic, it is
necessary to strengthen the in-hospital mental health resources,
implementing mechanisms for surveillance and intervention and
expanding telehealth-based modalities (19).
Children and adolescents are overall less severely affected by
COVID-19 than adults and elderly patients. The evaluation of
the clinical outcome of SARS-CoV-2 infection in children and
adolescents was beyond the scope of this article. Overall, in the
3-month study period, the total number of children evaluated
and admitted with COVID-19 was low and even fewer required
admission to the ICU (20). The clinical impact of infection in
children and the burden of the disease on the clinical activities
of children’s hospitals was unknown at the beginning of the
pandemic. Preparedness plans were oriented toward providing
care to a possible high volume of SARS-CoV-2 infected children.
Only two hospitals have designated bed spaces for adults with
COVID-19 and only one admitted adults with COVID-19. The
paediatric staff of four hospitals helped the staff of adult units
to cover shortages. The present data, as previously reported,
confirm that the COVID-19 emergency proved to be more
logistical than clinical in children, requiring more organizational
efforts than medical assistance (21, 22). At the same time, the
eight hospitals that completed the survey experienced substantial
decreases in all admissions, in comparison to the same period
in 2019, especially to emergency departments, consistent with
previous reports. Lazzerini et al. found a reduction ranging from
73 to 88% in Italian paediatric emergency department visits in
the period March 1–27, 2020, compared to 2019 and 2018 (23).
Ciofi Degli Atti (24) reported a 68% reduction in the mean
daily emergency department visits and a 31% reduction in urgent
hospitalizations from January 1 to April 20, 2020 compared to
the 2 months before (24). A significant reduction in the number
of outpatient visits, among the other routine activities of the
hospitals involved in this study, was observed. The decrease in
the number of outpatient visits was less evident where the burden
of the pandemic during the study period was lower such as in
Helsinki and Rotterdam. It could not be excluded that differences
in the hospital organization and in the country approach to the
pandemic could have influenced these results. Concerns have
been raised that the number of children who delay seeking
medical attention, from vaccines to surgery, is increasing (25).
This delayed and late presentation has been defined as “collateral
damage” due to an unintended effect of lockdown and social
distancing that is more harmful for children’s health than the
virus itself (26). Sporadic cases of delayed access to care for
children with severe diseases (25, 27, 28) and adults with fatal
conditions such as strokes (29) or cardiac diseases (30) have been
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reported. In both adults and children, reluctance to seek medical
care is probably correlated with restrictionmeasures and with the
fear of potential exposure to COVID-19 (23).
After the critical phase of strict social distancing and
lockdown, the strategies for the resumption of clinical activities
were investigated. Although all the participating hospitals have
planned a stepwise approach for the resumption of activities in
the safest possible way, different strategies were applied. While
there was an agreement with regard to the reorganization of
spaces and flows of patients with active source control measures,
major differences were observed in the testing approach to
patients, caregivers and healthcare professionals. Nasopharyngeal
swabs, the preferred testing strategy for healthcare professionals,
were performed on all parents/caregivers entering the facility
only in one hospital. It can be speculated that the different
timing and evolution of the pandemic across European countries
may have impacted the strategic approach of each hospital,
influencing the response at the time of the survey.
In view of the low number of children admitted in the
first phase of the pandemic and of the restrictions to routine
hospital activities, centralization of children with known SARS-
CoV-2 infection to a single referral hospital was explored as a
possible strategy. Although this approach has been successfully
implemented and described before (24, 31), only three hospitals
expressed a favourable opinion. Whether centralizing children
with known SARS-CoV-2 infection is effective in order
to optimize workforce and resources, decrease the risk of
delayed access to care and reduce the disruption of services,
especially for children with underlying chronic conditions,
should be evaluated.
The present study has some limitations. First, it reports on the
approach to the pandemic of a limited number of hospitals from
different countries with different SARS-CoV-2 epidemiology.
Furthermore, a hospital’s overall service delivery environment is
heavily influenced by its basic infrastructure, a factor that could
have impacted the responses. Finally, the response rate to the
survey was high but, as expected, not complete. Despite these
limitations, our study provides for the first time a perspective on
COVID-19 preparedness among eight large European children’s
hospitals, on the impact of the pandemic on the hospital activities
and, more importantly, on the strategies adopted to restart the
paediatric health care services.
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